Though 2019 was a down year for merger and acquisition activity, there were still some notable deals that had broader repercussions for their respective industries.

According to the Boston Consulting Group, there were 15,400 deals through the first half of 2019 — about 3,000 fewer than the first half of 2018. Deal value declined double-digits in Europe and Asia, though North America deal values were up 16 percent.

Here are some of the most notable deals of 2019, and the effect that they could still have going forward:

United Technologies + Raytheon

The all-stock deal between the two firms created a juggernaut defense and aerospace force worth $121 billion. Together, the united companies will become the second-largest in their field in terms of annual revenue at $74 billion, following only Boeing. It will also earn approximately $41 billion in military sales, more than half of its total revenue.

United Technologies Chairman and CEO Greg Hayes will take the reins of the newly formed company, with the deal expected to close in the first half of 2020. United Technologies shareholders own 57 percent of the company, while Raytheon will own about 43 percent.

Bristol-Myers Squibb + Celgene

Bristol-Myers Squibb's cash-and-stock acquisition of Celgene helps further cement itself as a leader in the biopharmaceutical space. Including debt, this was the largest health-care deal on record according to Refinitiv.

Celgene helped augment Bristol's cancer drug portfolio and also gave the new parent company the scale to compete for at least the near-term future. The two companies together have nine products and report more than $1 billion in annual sales.

Saudi Aramco + Saudi Basic Industries Corporation

Saudi Aramco purchased a 70 percent stake in Saudi Basic Industries Corporation, a chemical and metals manufacturing company and the largest public company in the Middle East. The world's largest oil producer purchased the shares from Saudi Arabia's wealth fund, which could help boost the country's economy and expand its businesses past oil. The deal also gives Aramco the ability to grow its refining and petrochemical sectors.

CBS and Viacom

The on-again-off-again couple of the bunch decided to give it another go. Existing CBS shareholders own 61 percent of ViacomCBS, while Viacom shareholders own 39 percent. However, it is Viacom CEO Bob Bakish who runs the combined company, while acting CBS CEO Joe Ianniello will become chairman of CBS and run the media division.

ViacomCBS, now worth about $30 billion, will become a larger entity more equipped to compete against giants like Disney-Fox and streaming newcomers like Netflix. It is the parent company to cable channels like MTV, Nickelodeon, and Comedy Central, as well as the CBS broadcast network and Showtime. It will also have 140,000 episodes of TV, more than 3,600 movies, and is expected to bring in more than $23 billion in revenue.

Canopy + Acreage

Canada's leading marijuana producer Canopy is set to acquire American cannabis company Acreage in a deal worth $3.4 billion. It could create the world's largest cannabis company, contingent on a gigantic "if." The transaction will only go through when the U.S. legalizes marijuana, so it could be years — if ever — before this comes to fruition.

Share:
More In Business
Rare Dom Pérignon champagne from Charles and Diana’s wedding fails to sell during Denmark auction
A rare magnum of Dom Pérignon Vintage 1961 champagne that was specially produced for the 1981 wedding of Prince Charles and Lady Diana has failed to sell during an auction. Danish auction house Bruun Rasmussen handled the bidding Thursday. The auction's house website lists the bottle as not sold. It was expected to fetch up to around $93,000. It is one of 12 bottles made to celebrate the royal wedding. Little was revealed about the seller. The auction house says the bids did not receive the desired minimum price.
New York Times, after Trump post, says it won’t be deterred from writing about his health
The New York Times and President Donald Trump are fighting again. The news outlet said Wednesday it won't be deterred by Trump's “false and inflammatory language” from writing about the 79-year-old president's health. The Times has done a handful of stories on that topic recently, including an opinion column that said Trump is “starting to give President Joe Biden vibes.” In a Truth Social post, Trump said it might be treasonous for outlets like the Times to do “FAKE” reports about his health and "we should do something about it.” The Republican president already has a pending lawsuit against the newspaper for its past reports on his finances.
OpenAI names Slack CEO Dresser as first chief of revenue
OpenAI has appointed Slack CEO Denise Dresser as its first chief of revenue. Dresser will oversee global revenue strategy and help businesses integrate AI into daily operations. OpenAI CEO Sam Altman recently emphasized improving ChatGPT, which now has over 800 million weekly users. Despite its success, OpenAI faces competition from companies like Google and concerns about profitability. The company earns money from premium ChatGPT subscriptions but hasn't ventured into advertising. Altman had recently announced delays in developing new products like AI agents and a personal assistant.
Trump approves sale of more advanced Nvidia computer chips used in AI to China
President Donald Trump says he will allow Nvidia to sell its H200 computer chip used in the development of artificial intelligence to “approved customers” in China. Trump said Monday on his social media site that he had informed China’s leader Xi Jinping and “President Xi responded positively!” There had been concerns about allowing advanced computer chips into China as it could help them to compete against the U.S. in building out AI capabilities. But there has also been a desire to develop the AI ecosystem with American companies such as chipmaker Nvidia.
Load More